Resources

Filter:

Read more

Dr Nik Sabharwal testimonial for Caristo

Customer Review: Dr Nik Sabharwal, Consultant Cardiologist, Oxford Heart Centre

When a patient is already on high dose statins, what else can you do to address atypical chest pain? Watch…

Read more

Dr Martin Laser quote for Caristo

Customer Review: Dr Martin Laser, Cardiologist, Parcside Clinic Germany,

Dr Martin Laser, Cardiologist, Parcside Clinic Germany, shares his experience of using CaRi-Heart® Analysis to prescribe a more personalised treatment…

Read more

Customer Review: Dr Alain Tavildari, Cardiologist, Axium Clinic

Dr Alain Tavildari, Cardiologist, Axium Clinic used CaRi-Heart® Analysis to understand his patient René’s cardiovascular risk levels and impact of…

Read more

odoco_colchicine_tablets_agepha_pharma_

Caristo Diagnostics Applauds FDA Approval of Colchicine as First Anti-Inflammatory Drug for Cardiovascular Disease

Colchicine’s Approval Heightens the Need for Technologies Detecting Inflammation Specifically Related to Coronary Arteries OXFORD, England, June 22, 2023 — Caristo Diagnostics…

Read more

Quote by Frank Cheng, CEO, Caristo Diagnostics

CEO Spotlight: Frank Cheng, Caristo Diagnostics

Caristo’s Frank Cheng speaks with OUI on transforming heart disease diagnostics, the evolution of Oxford, and the future of one…

Read more

Article in Nature Reviews Cardiology Publication

Clinical quantitative coronary artery stenosis and coronary atherosclerosis imaging: a Consensus Statement from the Quantitative Cardiovascular Imaging Study Group

Abstract The detection and characterization of coronary artery stenosis and atherosclerosis using imaging tools are key for clinical decision-making in…

Read more

Caristo Series A announcement

Caristo Diagnostics Completes Series A Financing and Welcomes New CEO to Advance Ground-Breaking AI Technology for Cardiac Disease Detection

$16 Million Investment Led by Oxford Science Enterprises and Joined by Multiple Institutional Investors OXFORD, England, April 17, 2023 /PRNewswire/ — Caristo Diagnostics Limited, a global…

Read more

Silicon Canals reports Caristo's Series A announcement

Oxford-based Caristo Diagnostics bags €14.7M for AI-powered cardiac disease detection; appoints new CEO

Oxford-based Caristo Diagnostics, a company that specialises in cardiac and vascular disease diagnostics and risk prediction, announced on Monday, April…


View Resources Archive

Get in touch for more information.